Delivery Order SPE2DB22D3011-SPE2DB25FQ1HM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,190.65. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count) with a ceiling value of $1,051.66. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 2, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,386.06. This firm fixed-price delivery order, which is expected to be completed by July 30, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.17 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count supply) on June 9, 2025, with completion scheduled for June 10, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with a ceiling value of $2,358.46. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,673.10. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 5, 2025. The product will be performed and delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,612.72 to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count supply) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count) with a ceiling value of $4,875.37. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement channels. The order is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,992.32 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ1HMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a ceiling value of $1,173.84. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for completion by June 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999.99 million through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The Methylphenidate ER supply falls within the company's extensive offerings of generic and brand-name medications across multiple therapeutic categories, demonstrating the vendor's critical role in maintaining pharmaceutical inventory for federal medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/17/25 |